Snam

Q1 22: unregulated activities continued to make their mark

13/05/22 -"Snam’s Q1 22 EBITDA was up 5.2% yoy to €588m driven by RAB growth, higher volumes and a one-off sale of gas inventories that more than offset a cut in the regulated WACC. The continuing expansion of ..."

PDF page sample
Pages
58
Language
English
Published on
13/05/22
Download
You may also be interested by these reports :
13/11/26
ACCIONA delivered a solid 9M26 performance, driven by Nordex’s margin recovery and firmer achieved power prices. However, the Group has abandoned its ...
12/11/26
A solid 9M26 delivery, with Enel’s integrated model once again proving its resilience. Ordinary EBITDA rose 4.0% to €17.95bn, 1.4% ahead of ...
12/11/26
We raise our 2026E adj. EPS from €2.93 to €3.30, now towards the upper end of the €2.60-3.30 range. The revision is driven mainly by Supply & ...
11/11/26
Solid 9M 26, comfortably on track. Adjusted EBITDA reached €2,402m, +8.1% YoY (+10.6% ex the 2025 deflator one-off), driven by RAB growth, OLT ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO